Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Allogeneic ABCB5 ⁺ mesenchymal stem cells for treatment-refractory chronic venous ulcers: a phase I/IIa clinical trial.

Autor: Kerstan A; Department of Dermatology, Venereology, and Allergology, University Hospital Würzburg, Würzburg, Germany., Dieter K; RHEACELL GmbH & Co. KG, Heidelberg, Germany., Niebergall-Roth E; TICEBA GmbH, Heidelberg, Germany., Dachtler AK; RHEACELL GmbH & Co. KG, Heidelberg, Germany., Kraft K; RHEACELL GmbH & Co. KG, Heidelberg, Germany., Stücker M; Department of Dermatology, St. Josef Hospital Bochum, Ruhr University Bochum, Bochum, Germany., Daeschlein G; Department of Dermatology, University Medicine Greifswald, Greifswald, Germany., Jünger M; Department of Dermatology, University Medicine Greifswald, Greifswald, Germany., Görge T; Department of Dermatology, University Hospital Münster, Münster, Germany., Meyer-Pannwitt U; pro scientia med at the Department of Clinical Research and Development, MARE Clinic, Kiel, Germany., Erfurt-Berge C; Department of Dermatology, University Hospital Erlangen, Erlangen, Germany., von Engelhardt C; Klinische Forschung Schwerin GmbH, Schwerin, Germany., Klare A; Klinische Forschung Hamburg GmbH, Hamburg, Germany., Pfeiffer C; Department of Dermatology and Allergic Diseases, University Hospital, Ulm, Germany., Esterlechner J; TICEBA GmbH, Heidelberg, Germany., Schröder HM; RHEACELL GmbH & Co. KG, Heidelberg, Germany., Gasser M; Department of Surgery, University Hospital Würzburg, Würzburg, Germany., Waaga-Gasser AM; Department of Surgery, University Hospital Würzburg, Würzburg, Germany.; Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Goebeler M; Department of Dermatology, Venereology, and Allergology, University Hospital Würzburg, Würzburg, Germany., Ballikaya S; TICEBA GmbH, Heidelberg, Germany., Sadeghi S; TICEBA GmbH, Heidelberg, Germany., Murphy GF; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Orgill DP; Division of Plastic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Frank NY; Department of Medicine, VA Boston Healthcare System, Boston, MA, USA.; Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Transplant Research Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA., Ganss C; RHEACELL GmbH & Co. KG, Heidelberg, Germany.; TICEBA GmbH, Heidelberg, Germany., Scharffetter-Kochanek K; Department of Dermatology and Allergic Diseases, University Hospital, Ulm, Germany., Frank MH; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Transplant Research Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.; School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia., Kluth MA; RHEACELL GmbH & Co. KG, Heidelberg, Germany.; TICEBA GmbH, Heidelberg, Germany.

Publikováno v: JID innovations : skin science from molecules to population health [JID Innov] 2022 Jan; Vol. 2 (1). Date of Electronic Publication: 2021 Oct 25.

The Synthetic Tie2 Agonist Peptide Vasculotide Protects Renal Vascular Barrier Function In Experimental Acute Kidney Injury

Autor: Rübig, E.C. (Eva), Stypmann, J. (Jörg), Van Slyke, P. (Paul), Dumont, D.J. (Daniel), Spieker, G.T. (Georg), Buscher, K. (Konrad), Reuter, S.J. (Stefan), Görge, T. (Tobias), Pavenstädt, H. (Hermann), Kümpers, P. (Philipp)

Microvascular barrier dysfunction plays a major role in the pathophysiology of acute kidney injury (AKI). Angiopoietin-1, the natural agonist ligand for the endothelial-specific Tie2 receptor, is a non-redundant endothelial survival and vascular stab

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______517::1bcd66d9d7bafea38c61718b040b70c4
https://repositorium.uni-muenster.de/transfer/miami/ea597e54-ae86-405d-9350-aa7cabf7928e